Global Glucagon-Like Peptide-1 (GLP-1) Receptor agonists Market Size, Industry Trends, Share and Forecast 2020-2026

1. Orion Market Research Global Glucagon-Like Peptide-1 (GLP-1) Receptor agonists Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our Global Glucagon-Like Peptide-1 (GLP-1) Receptor agonists Market: https://www.omrglobal.com/request-sample/glucagon-like-peptide-1-glp-1-receptor-agonists-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. GLP-1 receptor agonists market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026). The increasing advancement in drug development along with the presence of a strong product pipeline is anticipated to drive the growth of the global market. GLP-1 receptor agonists are a category of antidiabetic agents that performs functioning of the glucagon-like peptide. GLP-1 is a natural incretin compound that influences the body functioning once they get released from the gut during digestion. The growing prevalence of obesity and the geriatric population that leads to diabetes are some other factors anticipated to drive the growth of the global market. A full Report of Global Glucagon-Like Peptide-1 (GLP-1) Receptor agonists Market is Available at: https://www.omrglobal.com/industry-reports/glucagon-like-peptide-1-glp-1-receptor-agonists- market According to the Global Burden of Diseases, obesity is one of the leading factors for premature death and has 4.7 million deaths across the globe in 2017. Around8 % of mortality was attributed to obesity in 2017 across the globe. More than 13% of adults are obese and 39% of adults are overweight across the globe. Increasing the incidence of obesity promotes the chances of developing type2 diabetes which is the most common type of diabetes across the globe. Therefore, the high prevalence of obesity is anticipated to drive the demand for medications that are required in the treatment of type 2 diabetes. However, the failure of medications is anticipated to hinder the growth of the global GLP-1 receptor agonists market. For instance, in July 2017, GlaxoSmithKline Plc had discontinued the manufacturing and distribution of Tanzeum owing to the limited prescription of the drug along with its declining sales. Request a Free Sample of our Global Glucagon-Like Peptide-1 (GLP-1) Receptor agonists Market: https://www.omrglobal.com/request-sample/glucagon-like-peptide-1-glp-1-receptor-agonists-market Global GLP-1 Receptor Agonists Market Segmentation By Drug Type •Exenatide •Liraglutide •Lixisenatide •Dulaglutide Regional Analysis •North America •US •Canada •Europe •UK •Germany

3. •Italy •Spain •France •Rest of Europe •Asia-Pacific •China •India •Japan •Rest of Asia-Pacific •Rest of the World Company Profiles •AstraZeneca PLC •Bristol Mayer Squibb, Co. •Eli Lilly & Company •Merck & Co., Inc. •Novo Nordisk A/S •Sanofi SA For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/glucagon-like-peptide-1-glp-1-receptor-agonists-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404